In recent years, normothermic machine perfusion (NMP) has emerged in conversation surrounding organ preservation and transplantation techniques with the goal of improving patient and clinical outcomes. This is in great attempt to address the rate of non-utilization and the shortage of available organs in kidney transplantation. This focus in mind, normothermic perfusion presents itself as a potential tool to mimic physiological conditions and improve current preservation methods, such as static cold storage. This review serves to improve understanding of the observed connection between the consequences of ischemia and reperfusion injury and traditional preservation techniques as well as how renal NMP may mitigate these issues. Previous studies suggest that reducing time in static cold storage methods by promoting the normothermic perfusion model results in decreased delayed graft function and post-transplant complications. This review also aims to present the immense clinical potential NMP has on future kidney transplantation success and what this means for the fields of nephrology and transplantation. While great strides have been made to evaluate normothermic perfusion’s impact on kidney graft viability and transplant success, future research into unified protocol, clinically relevant biomarkers, cost-utility analysis, and use with associated therapeutic and imaging modalities is paramount.
DiRitoJRHosgoodSAReschkeM, et al. Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys. Am J Transplant2021; 21: g161–173.
2.
PericoNRuggenentiPScalamognaM, et al. Tackling the shortage of donor kidneys: how to use the best that we have. Am J Nephrol2003; 23: 245–259.
3.
AubertOReesePPAudryB, et al. Disparities in acceptance of deceased donor kidneys between the United States and France and estimated effects of increased US acceptance. JAMA Intern Med2019; 179: 1365–1374.
4.
HamedMOChenYPaseaL, et al. Early graft loss after kidney transplantation: risk factors and consequences. Am J Transplant2015; 15: 1632–1643.
5.
DiRitoJRHosgoodSATietjenGT, et al. The future of marginal kidney repair in the context of normothermic machine perfusion. Am J Transplant2018; 18: 2400–2408.
6.
BhattacharjeeRNPatelSVBSunQ, et al. Renal protection against ischemia reperfusion injury: hemoglobin-based oxygen carrier-201 versus blood as an oxygen carrier in ex vivo subnormothermic machine perfusion. Transplantation2020; 104: 482–489.
7.
DorweilerBPrueferDAndrasiTB, et al. Ischemia-reperfusion injury: pathophysiology and clinical implications. Eur J Trauma Emerg Surg2007; 33: 600–612.
8.
HamarMUrbanellisPKathsMJ, et al. Normothermic ex vivo kidney perfusion reduces warm ischemic injury of porcine kidney grafts retrieved after circulatory death. Transplantation2018; 102: 1262–1270.
9.
MalekMNematbakhshM. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J Renal Inj Prev2015; 4: 20–27.
10.
PonticelliC. Ischaemia-reperfusion injury: a major protagonist in kidney transplantation. Nephrol Dial Transplant2014; 29: 1134–1140.
11.
WongGTeixeira-PintoAChapmanJR, et al. The impact of total ischemic time, donor age and the pathway of donor death on graft outcomes after deceased donor kidney transplantation. Transplantation2017; 101: 1152–1158.
12.
AntoineCSavoyeEGaudezF, et al. Kidney transplant from uncontrolled donation after circulatory death: contribution of normothermic regional perfusion. Transplantation2020; 104: 130–136.
13.
HosgoodSABarlowADHunterJP, et al. Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants. Br J Surg2015; 102: 1433–1440.
14.
KathsJMEcheverriJGoldaracenaN, et al. Eight-hour continuous normothermic ex vivo kidney perfusion is a safe preservation technique for kidney transplantation: a new opportunity for the storage, assessment, and repair of kidney grafts. Transplantation2016; 100: 1862–1870.
15.
MazilescuLIUrbanellisPKathsMJ, et al. Prolonged normothermic ex vivo kidney perfusion is superior to cold nonoxygenated and oxygenated machine perfusion for the preservation of DCD porcine kidney grafts. Transplant Direct2021; 7: e751.
16.
MellatiALo FaroLDumbillR, et al. Kidney normothermic machine perfusion can be used as a preservation technique and a model of reperfusion to deliver novel therapies and assess inflammation and immune activation. Front Immunol2022; 13: 850271.
17.
ChenGWangCZhaoY, et al. Evaluation of quality of kidneys from donation after circulatory death/expanded criteria donors by parameters of machine perfusion. Nephrology (Carlton)2018; 23: 103–106.
18.
HosgoodSABarlowADDormerJ, et al. The use of ex-vivo normothermic perfusion for the resuscitation and assessment of human kidneys discarded because of inadequate in situ perfusion. J Transl Med2015; 13: 329.
19.
HosgoodSASaeb-ParsyKWilsonC, et al. Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation. BMJ Open2017; 7: e012237.
20.
HosgoodSAThompsonEMooreT, et al. Normothermic machine perfusion for the assessment and transplantation of declined human kidneys from donation after circulatory death donors. Br J Surg2018; 105: 388–394.
21.
NicholsonMLHosgoodSA. Renal transplantation after ex vivo normothermic perfusion: the first clinical study. Am J Transplant2013; 13: 1246–1252.
22.
UrbanellisPHamarMKathsJM, et al. Normothermic ex vivo kidney perfusion improves early DCD graft function compared with hypothermic machine perfusion and static cold storage. Transplantation2020; 104: 947–955.
23.
HosgoodSAvan HeurnENicholsonML. Normothermic machine perfusion of the kidney: better conditioning and repair?Transpl Int2015; 28: 657–664.
24.
KathsJMEcheverriJLinaresI, et al. Normothermic ex vivo kidney perfusion following static cold storage-brief, intermediate, or prolonged perfusion for optimal renal graft reconditioning?Am J Transplant2017; 17: 2580–2590.
25.
BlumMFLiuQSolimanB, et al. Comparison of normothermic and hypothermic perfusion in porcine kidneys donated after cardiac death. J Surg Res2017; 216: 35–45.
26.
ElliottTRNicholsonMLHosgoodSA. Normothermic kidney perfusion: An overview of protocols and strategies. Am J Transplant2021; 21: 1382–1390.
27.
HosgoodSAPatelMNicholsonML. The conditioning effect of ex vivo normothermic perfusion in an experimental kidney model. J Surg Res2013; 182: 153–160.
28.
MazilescuLIUrbanellisPKimSJ, et al. Normothermic ex vivo kidney perfusion for human kidney transplantation: first North American results. Transplantation2022; 106: 1852–1859.
29.
PoolMBFHamelinkTLvan GoorH, et al. Prolonged ex-vivo normothermic kidney perfusion: the impact of perfusate composition. PLoS One2021; 16: e0251595.
30.
SchutterRLantingaVAHamelinkTL, et al. Magnetic resonance imaging assessment of renal flow distribution patterns during ex vivo normothermic machine perfusion in porcine and human kidneys. Transpl Int2021; 34: 1643–1655.
31.
WeissenbacherALo FaroLBoubriakO, et al. Twenty-four-hour normothermic perfusion of discarded human kidneys with urine recirculation. Am J Transplant2019; 19: 178–192.
32.
KathsJMCenJYChunYM, et al. Continuous normothermic ex vivo kidney perfusion is superior to brief normothermic perfusion following static cold storage in donation after circulatory death pig kidney transplantation. Am J Transplant2017; 17: 957–969.
33.
PadillaMCollEFernández-PérezC, et al. Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion. Am J Transplant2021; 21: 3618–3628.
34.
ChatauretNCoudroyRDelpechPO, et al. Mechanistic analysis of nonoxygenated hypothermic machine perfusion’s protection on warm ischemic kidney uncovers greater eNOS phosphorylation and vasodilation. Am J Transplant2014; 14: 2500–2514.
35.
PefanisAIerinoFLMurphyJM, et al. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int2019; 96: 291–301.
36.
LindemanJHWijermarsLGKostidisS, et al. Results of an explorative clinical evaluation suggest immediate and persistent post-reperfusion metabolic paralysis drives kidney ischemia reperfusion injury. Kidney Int2020; 98: 1476–1488.
37.
BasileDPBonventreJVMehtaR, et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J Am Soc Nephrol2016; 27: 687–697.
38.
LiuJKumarSDolzhenkoE, et al. Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion. JCI Insight2017; 2: e94716.
39.
SolhjouZAtharHXuQ, et al. Emerging therapies targeting intra-organ inflammation in transplantation. American Journal of Transplantation2015; 15: 305–311.
40.
HameedAMLuDBPatrickE, et al. Brief normothermic machine perfusion rejuvenates discarded human kidneys. Transplantation Direct2019; 5: e502.
41.
LohmannSPoolMBFRozenbergKM, et al. Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: a porcine renal autotransplantation study. Am J Transplant2021; 21: 2348–2359.
42.
ThompsonERBatesLIbrahimIK, et al. Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation. Am J Transplant2021; 21: 1402–1414.
43.
ArykbaevaASde VriesDKDoppenbergJB, et al. Metabolic needs of the kidney graft undergoing normothermic machine perfusion. Kidney Int2021; 100: 301–310.
44.
AdamsTDHosgoodSANicholsonML. Physiological effects of altering oxygenation during kidney normothermic machine perfusion. Am J Physiol Renal Physiol2019; 316: F823–F829.
45.
MishraJMaQKellyC, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol2006; 21: 856–863.
46.
HanWKBaillyVAbichandaniR, et al. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int2002; 62: 237–244.
47.
HamelinkTLOgurluBDe BeuleJ, et al. Renal normothermic machine perfusion: the road toward clinical implementation of a promising pretransplant organ assessment tool. Transplantation2022; 106: 268–279.
48.
LeveyASPerroneRDMadiasNE. Serum creatinine and renal function. Annu Rev Med1988; 39: 465–490.
49.
WebbANLesterELWShapiroAMJ, et al. Cost-utility analysis of normothermic machine perfusion compared to static cold storage in liver transplantation in the Canadian setting. Am J Transplant2022; 22: 541–551.
50.
HosgoodSACallaghanCJWilsonCH, et al. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial. Nat Med2023; 29: 1511–1519.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
